Advanced-therapy medicinal product (ATMP) classification was confirmed for TILT-123 by the Committee for Advanced Therapies (CAT) of European Medicines Agency. The report summary can be found here
Latest News
Upcoming Events
Please contact our business development team to meet us at the following events: